Author

Sergey Popov

Institute of Cancer ResearchPrimary ORCID profile (0000-0003-1172-3557 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Sergey PopoviD1 paper · Endocrinology Research Center

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Anette M. HøyeiD· 1 shared Ann‐Marie BakeriD· 1 shared Chris JonesiD· 1 shared Hans Skovgaard PoulseniD· 1 shared Jan E. StrøbechiD· 1 shared Janine Terra ErleriD· 1 shared Lara PerrymaniD· 1 shared Lasse G. LorentzeniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anette M. HøyeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cleavage of the vascular matrix attracts glioblastoma cells to infiltrate the brain parenchyma

Lara Perryman, Anette M. Høye, Thomas R. Cox, Ann‐Marie Baker, Jan E. Strøbech, Lidia E. Leonte, Lukram Babloo Singh, Sergey Popov, Lasse G. Lorentzen, Raphael Reuten, Hans Skovgaard Poulsen, Michael J. Davies, Chris Jones, Janine Terra Erler

This study identifies LOX-mediated cleavage of the vascular matrix as a mechanism driving glioblastoma infiltration and suggests targeting LOX as a therapeutic strategy.

bioRxiv · Aug 2, 2024 · PreprintCancer Biology